Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laruelle

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Synapse (New York, N.Y.)|April 1, 1993
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primatesM Laruelle, R M Baldwin, R T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECTC H van Dyck, J P Seibyl, R T Malison, et al.
European Journal of Nuclear Medicine|January 1, 1995
Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primatesB E Scanley, M S al-Tikriti, M S Gandelman, et al.
Nuclear Medicine and Biology|October 1, 1994
Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primatesR M Baldwin, Y Zea-Ponce, S S Zoghbi, et al.
Nuclear Medicine and Biology|July 1, 1995
Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCITM S al-Tikriti, Y Zea-Ponce, R M Baldwin, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|November 1, 1992
Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primatesS S Zoghbi, R M Baldwin, J P Seibyl, et al.
Synapse (New York, N.Y.)|May 7, 1999
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756A Abi-Dargham, N Simpson, L Kegeles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transportersJ P Seibyl, M Laruelle, C H van Dyck, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Synapse (New York, N.Y.)|April 1, 1993
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primatesM Laruelle, R M Baldwin, R T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECTC H van Dyck, J P Seibyl, R T Malison, et al.
European Journal of Nuclear Medicine|January 1, 1995
Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primatesB E Scanley, M S al-Tikriti, M S Gandelman, et al.
Nuclear Medicine and Biology|October 1, 1994
Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primatesR M Baldwin, Y Zea-Ponce, S S Zoghbi, et al.
Nuclear Medicine and Biology|July 1, 1995
Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCITM S al-Tikriti, Y Zea-Ponce, R M Baldwin, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|November 1, 1992
Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primatesS S Zoghbi, R M Baldwin, J P Seibyl, et al.
Synapse (New York, N.Y.)|May 7, 1999
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756A Abi-Dargham, N Simpson, L Kegeles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transportersJ P Seibyl, M Laruelle, C H van Dyck, et al.
Pageof 11